[Drugs and anti-drug antibody levels in the management of patients with inflammatory bowel disease]

Gastroenterol Hepatol. 2016 Apr;39(4):265-72. doi: 10.1016/j.gastrohep.2015.09.012. Epub 2015 Nov 19.

[Article in Spanish]

Authors

María López-Ibáñez¹, Ignacio Marín-Jiménez²

Affiliations

¹ Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Marañón, Madrid, España.
² Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Marañón, Madrid, España. Electronic address: drnachomarin@hotmail.com.

PMID: 26601991
DOI: 10.1016/j.gastrohep.2015.09.012

No abstract available

MeSH terms

Antibodies / blood*
Antibodies, Monoclonal / immunology*
Humans
Inflammatory Bowel Diseases / drug therapy*
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Antibodies
Antibodies, Monoclonal
Tumor Necrosis Factor-alpha